Slingshot members are tracking this event:
Development of Omecamtiv Mecarbil Questionable to Continue to Phase 3 - Decision Expected This Year
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Sep 01, 2016
Related Keywords Omecamtiv Mecarbil, Japan, Heart Failure